Applied Biosciences Corp APPB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.10
- Bid/Ask
- $0.00 / $0.15
- Market Cap
- $2,820.19
- Volume/Avg
- 895 / 1,243
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also delivers high-quality consumer and over the counter THC-free cannabidiol products that promote overall health and wellbeing as well as testing and analytics capabilities to customers. The product portfolio includes soft gels, tinctures, hard candy, massage oil, hemp oil, and other products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 25
- Website
- https://www.appliedbiocorp.com
Valuation
|
Metric
|
APPB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
APPB
|
|---|---|
Quick Ratio | 0.05 |
Current Ratio | 0.11 |
Interest Coverage | −12.44 |
Quick Ratio
APPB
Profitability
|
Metric
|
APPB
|
|---|---|
Return on Assets (Normalized) | −72.56% |
Return on Equity (Normalized) | −686.32% |
Return on Invested Capital (Normalized) | −80.90% |
Return on Assets
APPB
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Vrrvpxnwkb | Gysggv | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Trrtffclcd | Kllmp | $68.9 Bil | |
HLN
| Haleon PLC ADR | Zxpkscnlr | Frrtc | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Jjwhnwdx | Qqbh | $14.7 Bil | |
VTRS
| Viatris Inc | Pdkrxkrm | Vydpv | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Sfxdncqf | Thlcn | $11.9 Bil | |
CTLT
| Catalent Inc | Snmjnkbhd | Pyxdr | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Jhlgrnzt | Rgwz | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Ljjshwfxn | Yvpc | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wxlvnphgw | Nyvqss | $3.5 Bil |